CCL2 and age-related macular degeneration: It is tempting to speculate that increased local levels of CCL2 observed during ageing (Chen et al., 2008) and in AMD patients (Jonas et al., 2010) promote retinal degeneration, not directly, but by priming the retina for the infiltration of systemic pro-inflammatory monocytes.